Universe Pharmaceuticals ...

NASDAQ: UPC · Real-Time Price · USD
3.56
-0.84 (-19.09%)
At close: Aug 14, 2025, 3:58 PM
3.49
-1.97%
Pre-market: Aug 15, 2025, 07:23 AM EDT

Universe Pharmaceuticals Income Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Revenue
23.02M 32.31M 40.14M 47.98M
Cost of Revenue
16.95M 21.99M 18.25M 22.66M
Gross Profit
6.07M 10.32M 21.89M 25.33M
Operating Income
-8.02M -3.53M -7.02M 13.59M
Interest Income
n/a n/a n/a n/a
Pretax Income
-8.12M -3.85M -7.98M 13.68M
Net Income
-8.73M -6.16M -8.74M 11.32M
Selling & General & Admin
10.44M 9M 21.3M 6.27M
Research & Development
3.03M 4.86M 7.62M 5.47M
Other Expenses
616.27K -17.53K -7.53K n/a
Operating Expenses
14.09M 13.84M 28.91M 11.74M
Interest Expense
278.17K 156.79K 162.4K 101.6K
Selling & Marketing Expenses
7.26M 6.78M 18.3M 2.97M
Cost & Expenses
31.04M 36.27M 47.16M 34.39M
Income Tax Expense
606.7K 2.25M 752.42K 2.36M
Shares Outstanding (Basic)
6.08K 5.92K 5.92K 5.27K
Shares Outstanding (Diluted)
6.08K 5.92K 5.92K 5.27K
EPS (Basic)
-1.44K -1.04K -1.48K 2.15K
EPS (Diluted)
-1.44K -1.04K -1.48K 2.15K
EBITDA
-7.36M -3.22M -6.4M 14.2M
EBIT
-7.84M -3.69M -6.93M 13.78M
Depreciation & Amortization
485.73K 508.79K 533.95K 446.88K